journal article·2024-06

Bioorthogonal In Situ Polymerization of Dendritic Agents for Hijacking Lysosomes and Enhancing Antigen Presentation in Cancer Cells

Dan Zhong, Xingyu Hou, Dayi Pan, Zhiqian Li, Qiyong Gong, Kui Luo

Advanced Materials· Volume 36· Issue 26
Publisher page

Abstract

Abstract A low‐generation lysine dendrimer, SPr‐G2, responds to intracellular glutathione to initiate bioorthogonal in situ polymerization, resulting in the formation of large assemblies in mouse breast cancer cells. The intracellular large assemblies of SPr‐G2 can interact with lysosomes to induce lysosome expansion and enhance lysosomal membrane permeabilization, leading to major histocompatibility complex class I upregulation on tumor cell surfaces and ultimately tumor cell death. Moreover, the use of the SPr‐G2 dendrimer to conjugate the chemotherapeutic drug, camptothecin (CPT), can boost the therapeutic potency of CPT. Excellent antitumor effects in vitro and in vivo are obtained from the combinational treatment of the SPr‐G2 dendrimer and CPT. This combinational effect also enhances antitumor immunity through promoting activation of cytotoxic T cells in tumor tissues and maturation of dendritic cells. This study can shed new light on the development of peptide dendritic agents for cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · RNA Interference and Gene Delivery · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiology Huaxi MR Research Center (HMRRC) Frontiers Science Center for Disease‐Related Molecular Network State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu 610041 China

Functional and Molecular Imaging Key Laboratory of Sichuan Province, and Research Unit of Psychoradiology Chinese Academy of Medical Sciences Chengdu 610041 China

Department of Radiology West China Xiamen Hospital of Sichuan University Xiamen 361000 China

Funding

National Natural Science Foundation of China · West China Hospital, Sichuan University · National Science and Technology Major Project · Science and Technology Department of Sichuan Province

References (48)

Show source-provided references
1. 10.1038/s41573-022-00615-z10.1038/s41573-022-00615-z ↗
2. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
3. 10.1038/s41556-018-0244-710.1038/s41556-018-0244-7 ↗
4. 10.1021/acs.nanolett.2c0054010.1021/acs.nanolett.2c00540 ↗
5. 10.1038/s41419-023-05677-410.1038/s41419-023-05677-4 ↗
6. 10.1016/j.cell.2023.07.01610.1016/j.cell.2023.07.016 ↗
7. 10.1038/s41467-022-35710-710.1038/s41467-022-35710-7 ↗
8. 10.1002/adma.20210470410.1002/adma.202104704 ↗
9. 10.1002/ange.20211426710.1002/ange.202114267 ↗
10. 10.1002/adma.20230424910.1002/adma.202304249 ↗
11. 10.1016/j.cclet.2022.10782710.1016/j.cclet.2022.107827 ↗
12. 10.1021/jacs.3c0303110.1021/jacs.3c03031 ↗
13. 10.1016/j.carbpol.2022.12036510.1016/j.carbpol.2022.120365 ↗
14. 10.1021/jacs.3c0268210.1021/jacs.3c02682 ↗
15. 10.1002/cptc.20230001810.1002/cptc.202300018 ↗
16. 10.1021/acs.biomac.2c0146910.1021/acs.biomac.2c01469 ↗
17. 10.1021/acsnano.2c1268510.1021/acsnano.2c12685 ↗
18. 10.7150/thno.8785410.7150/thno.87854 ↗
19. 10.1002/smll.20230106310.1002/smll.202301063 ↗
20. 10.1002/smtd.20220170810.1002/smtd.202201708 ↗
21. 10.1021/acs.nanolett.3c0178710.1021/acs.nanolett.3c01787 ↗
22. 10.1021/jacs.3c1025510.1021/jacs.3c10255 ↗
23. 10.1002/anie.20230642710.1002/anie.202306427 ↗
24. 10.1038/s41467-022-29693-810.1038/s41467-022-29693-8 ↗
25. 10.1038/s41467-017-01296-810.1038/s41467-017-01296-8 ↗
26. 10.1073/pnas.221530812010.1073/pnas.2215308120 ↗
27. 10.1016/j.jconrel.2020.10.04810.1016/j.jconrel.2020.10.048 ↗
28. 10.1002/wnan.167010.1002/wnan.1670 ↗
29. 10.1002/adma.20230726310.1002/adma.202307263 ↗
30. 10.1002/adma.20210700910.1002/adma.202107009 ↗
31. 10.1038/s41551-017-0130-910.1038/s41551-017-0130-9 ↗
32. 10.1021/ja800632510.1021/ja8006325 ↗
33. 10.1038/s41578-023-00617-210.1038/s41578-023-00617-2 ↗
34. 10.1021/acsnano.6b0341210.1021/acsnano.6b03412 ↗
35. 10.1073/pnas.97.2.74510.1073/pnas.97.2.745 ↗
36. 10.1074/jbc.M00345920010.1074/jbc.M003459200 ↗
37. 10.1016/S0169-409X(02)00179-510.1016/S0169-409X(02)00179-5 ↗
38. 10.1002/adfm.20230034810.1002/adfm.202300348 ↗
39. 10.1038/s41565-020-0643-310.1038/s41565-020-0643-3 ↗
40. 10.1016/j.ccr.2013.08.00310.1016/j.ccr.2013.08.003 ↗
41. 10.1038/s41586-020-2229-510.1038/s41586-020-2229-5 ↗
42. 10.1016/j.apsb.2021.03.04310.1016/j.apsb.2021.03.043 ↗
43. 10.1021/acs.nanolett.1c0146910.1021/acs.nanolett.1c01469 ↗
44. 10.1038/s41467-019-09566-310.1038/s41467-019-09566-3 ↗
45. 10.1002/adma.20231104310.1002/adma.202311043 ↗
46. 10.1021/jacs.2c0574310.1021/jacs.2c05743 ↗
47. 10.1038/s41565-021-00950-z10.1038/s41565-021-00950-z ↗
48. 10.1002/advs.20220524610.1002/advs.202205246 ↗